Citation Impact
Citing Papers
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
2007
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion
2007
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
Macrophages Promote the Invasion of Breast Carcinoma Cells via a Colony-Stimulating Factor-1/Epidermal Growth Factor Paracrine Loop
2005
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
2008
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice
2011
Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α
1995
Hallmarks of Cancer: The Next Generation
2011 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
2006 StandoutNature
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
2008
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas
2009
Endometrial Carcinomas
2011
Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis
1995
THE LOCALIZATION OF p34cdc2 IN THE CELLS OF NORMAL, HYPERPLASTIC, AND MALIGNANT EPITHELIAL AND LYMPHOID TISSUES OF THE ORAL CAVITY
1996 StandoutNobel
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
2009
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Ovarian cancer
2014 Standout
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
2015
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma
2001
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
2010
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Renal-Cell Carcinoma
1996 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Nonresolving Inflammation
2010 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Apoptosis and cancer: the genesis of a research field
2009
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content
2007
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Inferring tumor progression from genomic heterogeneity
2009
Prevention of Venous Thromboembolism
2004 Standout
Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas
1995
Cancer immunotherapy comes of age
2011 StandoutNature
Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas
1995
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Clonal evolution in cancer
2012 StandoutNature
Tumour necrosis factor and cancer
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
American Joint Committee on Cancer prognostic factors consensus conference
2000
Identification of human brain tumour initiating cells
2004 StandoutNature
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
2007
Cancer-related inflammation
2008 StandoutNature
The detection, treatment, and biology of epithelial ovarian cancer
2010
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
EGF, TGF-a, and EGF-R in Human Colorectal Adenocarcinoma
1998
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
The Rate of Bleeding Complications After Pharmacologic Deep Venous Thrombosis Prophylaxis
2006
Role of c-Src Tyrosine Kinase in G Protein-coupled Receptorand Gβγ Subunit-mediated Activation of Mitogen-activated Protein Kinases
1996 StandoutNobel
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
1997 StandoutNobel
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer
2003
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
Ovarian cancer cell–derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis
2007 Standout
Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
1995
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Expression of NM23 in Cell Lines Derived from Patients with Metastatic Renal Cell Carcinoma
1995
Cancer Cell Cycles
1996 StandoutScience
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
“Re-educating” tumor-associated macrophages by targeting NF-κB
2008
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
2015
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
2004
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery
2003
Cancer Genome Landscapes
2013 StandoutScience
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose
2007
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of A. Ayhan being referenced
Predicting Clinical Outcome in Patients Diagnosed with Synchronous Ovarian and Endometrial Cancer
2008
Expression of Amphiregulin, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastric Carcinomas
1993
Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas
2009
Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas
1993
The clonal evolution of metastases from primary serous epithelial ovarian cancers
2008
Expression of epidermal growth factor in human tissues
1991
Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours
2006
Loss of Heterozygosity at the bcl‐2 Gene Locus and Expression of bcl‐2 in Human Gastric and Colorectal Carcinomas
1994
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
2015
Transferrin Receptor Activity as a Marker in Transitional Cell Carcinoma of the Bladder
1991
Expression of several growth factors and their receptor genes in human colon carcinomas
1990
Establishment and Characterization of a Human Glioblastoma Multiforme Cell Line
1998
Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary
2009
Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue
1999
Expression of transforming growth factor alpha in human tissues: Immunohistochemical study and Northern blot analysis
1992
Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated Does not Have Biologic Validity Based on Molecular Genetic and In Vitro Drug Resistance Data
2008
Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas
1993
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
2009
The Inflammatory Cytokine Tumor Necrosis Factor-α Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer Cells
2007
A Role for Endothelin-2 and Its Receptors in Breast Tumor Cell Invasion
2004
Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study.
2001